MESA LABORATORIES INC /CO/

MLAB

MESA LABORATORIES INC /CO/

MLAB

Insider Sentiment (TTM):

Last Purchase:2026-03-10Last Sale:2026-06-22Shares Purchased (TTM):6,116Shares Sold (TTM):8,277

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:4,801,985Shares Outstanding:5,514,000Institutional Ownership Pct.:87.09%

Earnings Market Reaction:

Filing Date:2026-08-10Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets Current
Cash And Cash Equivalents At Carrying Value	31	27	29	20	21	27	31	24	28	28	28	36
Accounts Receivable Net Current	34	44	40	40	39	42	39	40	36	39	36	36
Inventory Net	27	26	27	28	28	25	28	30	32	33	36	33
Prepaid Expense And Other Assets Current	11	9	10	9	10	8	13	14	11	9	18	13
Assets Current	103	106	106	97	98	103	111	108	107	109	118	118
Assets Noncurrent
Property Plant And Equipment Net	30	31	32	32	32	32	32	32	31	32	32	29
Deferred Income Tax Assets Net	1	2	1	1	1	1	1	1	1	1	1	1
Other Assets Noncurrent	20	19	17	18	19	18	18	20	12	11	12	9
Finite Lived Intangible Assets Net	78	83	90	93	97	97	98	109	109	114	233	198
Goodwill	186	187	189	188	188	182	177	184	180	180	346	283
Assets	419	428	435	430	436	433	437	454	440	447	742	637
Liabilities Current
Accounts Payable Current	7	5	5	5	6	6	4	6	6	6	5	5
Employee Related Liabilities Current	13	19	14	10	10	18	14	9	8	10	9	8
Contract With Customer Liability Current	15	15	15	14	15	15	15	14	15	15	14	14
Accrued Liabilities Current	17	18	16	14	16	25	22	23	22	13	16	12
Secured Debt Current	6	6	5	5	4	4	4	4	4	0	-	-
Convertible Debt Current	-	0	0	0	97	97	97	97	-	0	-	-
Liabilities Current	57	62	54	48	149	164	156	153	55	44	44	40
Liabilities Noncurrent
Deferred Income Tax Liabilities Net	20	20	22	22	22	20	19	21	20	20	44	33
Other Liabilities Noncurrent	-	14	11	12	13	12	12	15	7	16	17	5
Secured Long Term Debt	60	61	63	64	66	67	68	69	70	0	-	-
Line Of Credit	77	85	98	106	14	10	27	36	42	51	62	0
Convertible Debt Noncurrent	-	-	-	-	-	0	0	0	97	171	171	171
Liabilities	230	242	248	252	263	274	282	293	290	301	339	249
Stockholders Equity
Common Stock Value	-377	375	-369	-365	-361	359	353	350	346	-344	341	338
Retained Earnings Accumulated Deficit	-184	-186	-181	-183	-185	-189	-181	-178	-181	-183	72	71
Accumulated Other Comprehensive Income Loss Net Of…	-4	-3	-1	-3	-4	-10	-17	-10	-14	-15	-10	-21
Stockholders Equity	189	186	187	178	172	160	155	161	151	145	403	388
Liabilities And Stockholders Equity	419	428	435	430	436	433	437	454	440	447	742	637
Allowance For Doubtful Accounts Receivable Current	2	3	3	2	1	1	1	1	1	1	1	1
Accumulated Depreciation Depletion And Amortizatio…	31	-	30	29	28	-	26	26	23	-	23	21
Common Stock No Par Value	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	25	25	25	25	25	25	25	25	25	25	25	25
Common Stock Shares Issued	6	6	6	6	6	5	5	5	5	5	5	5
Shares Outstanding	6	6	6	6	6	5	5	5	5	5	5	5

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2027	-	-	-	-	-	-	-	-	-	-	-	-
2026	18.23%	12.58%	38.16%	7.33%	7.69%	10.62%	10.51%	-6.08%	12.10%	-1.88%	-6.59%	-
2025	27.83%	22.12%	8.08%	-0.50%	13.02%	19.31%	1.66%	-12.79%	-15.04%	-6.89%	-31.93%	-33.08%
2024	-	-	-	-1.50%	14.20%	3.56%	10.37%	10.67%	4.07%	24.61%	49.25%	45.05%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	1.79	1.72	1.94	2.02	0.66	0.63	0.71	0.70	1.94	2.47	2.68	2.96
Quick Ratio	1.14	1.15	1.27	1.25	0.40	0.42	0.45	0.42	1.17	1.52	1.45	1.81
Working Capital	45.53M	44.37M	51.24M	49.14M	-51.24M	-61.28M	-45.03M	-45.25M	51.83M	65.04M	74.17M	77.85M
Leverage & Debt
Debt to Equity	1.22	1.30	1.33	1.41	1.53	1.71	1.82	1.81	1.92	2.07	0.84	0.64
Interest Coverage TTM	2.07	1.73	1.53	1.36	1.23	1.38	-24.21	-27.31	-35.49	-47.76	-0.05	0.71
Debt Ratio	0.55	0.56	0.57	0.59	0.60	0.63	0.64	0.64	0.66	0.67	0.46	0.39
Efficiency & Turnover
Asset Turnover TTM	0.58	0.58	0.57	0.55	0.55	0.55	0.40	0.42	0.41	0.39	0.30	0.33
Days Sales Outstanding TTM	53.70	63.05	58.15	59.77	56.20	61.36	57.32	61.19	58.05	68.89	67.23	66.74
Receivables Turnover TTM	6.80	5.79	6.28	6.11	6.49	5.95	6.37	5.96	6.29	5.30	5.43	5.47
Per Share Metrics
Diluted EPS TTM	0.83	1.21	0.67	-0.28	-0.11	-0.36	-45.95	-44.90	-46.15	-47.20	0.18	-0.13
Free Cash Flow Per Share TTM	9.50	5.49	5.18	5.07	4.28	7.85	7.92	6.67	7.74	7.72	7.55	6.75
Dividend Per Share TTM	0.78	0.80	0.79	0.79	0.64	0.64	0.64	0.64	0.64	0.64	0.64	0.64
Margin Metrics
Gross Profit Margin TTM	64.21%	63.53%	62.40%	62.15%	62.12%	62.61%	62.68%	62.47%	62.27%	61.64%	61.02%	60.49%
Operating Profit Margin TTM	9.00%	7.43%	6.96%	6.13%	5.70%	6.78%	-107.85%	-114.84%	-118.83%	-125.85%	-0.13%	1.50%
Net Profit Margin TTM	1.92%	2.69%	1.51%	-0.64%	-0.26%	-0.82%	-104.92%	-107.56%	-111.89%	-117.60%	0.45%	-0.34%
Growth Metrics
Net Revenue Growth (1Y)	3.04%	3.38%	4.12%	7.39%	8.33%	11.47%	11.68%	6.88%	2.02%	-1.32%	-4.27%	-4.08%
Net Income Growth (1Y)	-874.19%	-440.02%	-101.50%	-99.36%	-99.75%	-99.22%	-26,412.55%	34,160.95%	-13,860.80%	-27,438.28%	-164.71%	-81.97%
EPS Growth (1Y)	-847.92%	-434.29%	-101.47%	-99.37%	-99.76%	-99.23%	-26,238.07%	33,996.38%	-13,797.06%	-27,108.35%	-164.06%	-82.18%
Valuation Metrics
P/E TTM	117.32	72.53	115.92	-233.74	-824.22	-322.90	-2.84	-2.83	-1.85	-2.29	586.68	-775.63
P/B TTM	2.98	2.61	2.32	2.06	2.96	3.99	4.57	4.30	3.07	4.01	1.38	1.43
P/S TTM	2.26	1.95	1.75	1.50	2.11	2.65	2.98	3.04	2.07	2.69	2.61	2.60
Market Cap	563.15M	486.79M	432.86M	367.44M	511.02M	637.41M	708.58M	694.78M	462.32M	582.61M	556.17M	556.13M
Enterprise Value	598.08M	526.85M	471.76M	415.87M	656.92M	778.04M	846.34M	839.93M	604.09M	725.60M	698.91M	691.24M
Calculated Values
Free Cash Flow TTM	53.76M	30.27M	28.63M	27.92M	23.39M	42.56M	43.00M	36.09M	41.75M	41.57M	40.71M	36.37M
Net Debt	34.92M	40.05M	38.90M	48.43M	145.91M	140.63M	137.76M	145.15M	141.78M	142.98M	142.74M	135.12M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-22Sale

Owner: Sakys, John

Title: CFO

Shares: 2,827

Price/Share: $89.50

Value: $253,016.50

Shares Owned: 19,785

Relationship: Officer

Ownership: Direct

2026-06-22Sale

Owner: Archbold, Brian David

Title: SVP Operations

Shares: 2,516

Price/Share: $89.50

Value: $225,182.00

Shares Owned: 6,377

Relationship: Officer

Ownership: Direct

2026-06-22Sale

Owner: Crennen, Lyndsey Elizabet…

Title: CAO

Shares: 442

Price/Share: $89.50

Value: $39,559.00

Shares Owned: 2,020

Relationship: Officer

Ownership: Direct

2026-06-16Sale

Owner: Archbold, Brian David

Title: SVP Operations

Shares: 1,151

Price/Share: $101.27

Value: $116,561.77

Shares Owned: 3,710

Relationship: Officer

Ownership: Direct

2026-06-16Sale

Owner: Sakys, John

Title: CFO

Shares: 1,223

Price/Share: $101.27

Value: $123,853.21

Shares Owned: 16,538

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-22	Sakys, John	Officer	CFO	Direct	Sale	2,827	89.50	$253,016.50	19,785	4
2026-06-22	Archbold, Brian David	Officer	SVP Operations	Direct	Sale	2,516	89.50	$225,182.00	6,377	4
2026-06-22	Crennen, Lyndsey Elizabet…	Officer	CAO	Direct	Sale	442	89.50	$39,559.00	2,020	4
2026-06-16	Archbold, Brian David	Officer	SVP Operations	Direct	Sale	1,151	101.27	$116,561.77	3,710	4
2026-06-16	Sakys, John	Officer	CFO	Direct	Sale	1,223	101.27	$123,853.21	16,538	4
2026-06-16	Crennen, Lyndsey Elizabet…	Officer	CAO	Direct	Sale	118	101.27	$11,949.86	1,473	4
2026-03-10	Capone, Mark Christopher	Director	-	Direct	Purchase	1,301	76.35	$99,331.35	3,429	4
2026-03-10	Ladiwala, Shiraz Shabanal…	Director	-	Direct	Purchase	3,500	72.23	$252,805.00	8,523	4
2026-03-10	Tripeny, R Tony	Director	-	Direct	Purchase	1,315	76.00	$99,940.00	5,398	4
2025-06-16	Sakys, John	Officer	CFO	Direct	Sale	642	97.12	$62,351.04	12,865	4
2025-06-16	Archbold, Brian David	Officer	SVP Operations	Direct	Sale	472	97.12	$45,840.64	558	4
2025-06-16	Owens, Gary M	Officer	President and CEO	Direct	Sale	1,939	97.12	$188,315.68	45,824	4
2025-03-19	Owens, Gary M	Officer	President and CEO	Direct	Sale	21,000	123.91	$2,602,110.00	43,337	4
2024-10-29	Owens, Gary M	Officer	President and CEO	Direct	Sale	2,551	111.98	$285,660.98	43,337	4
2024-09-13	Archbold, Brian David	Officer	SVP Operations	Direct	Sale	1,499	125.00	$187,375.00	0	4
2023-12-15	Archbold, Brian David	Officer	SVP Operations	Direct	Sale	1,500	112.36	$168,540.00	558	4
2023-09-15	Schmieder, John Bradley	Director	-	Direct	Sale	1,000	123.74	$123,740.00	62,760	4
2023-09-13	Schmieder, John Bradley	Director	-	Direct	Sale	3,000	123.32	$369,960.00	66,760	4
2023-09-01	Owens, Gary M	Officer	President and CEO	Direct	Sale	2,000	142.82	$285,640.00	30,032	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

87.09%

Inst. Shares: 4,801,985

Shares Outstanding: 5,514,000

2025-12-31

84.66%

Inst. Shares: 4,683,364

Shares Outstanding: 5,532,000

2025-09-30

89.95%

Inst. Shares: 4,958,067

Shares Outstanding: 5,512,000

2025-06-30

94.05%

Inst. Shares: 5,139,632

Shares Outstanding: 5,465,000

2025-03-31

94.44%

Inst. Shares: 5,119,780

Shares Outstanding: 5,421,000

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	4,801,985	5,514,000	87.09%
2025-12-31	4,683,364	5,532,000	84.66%
2025-09-30	4,958,067	5,512,000	89.95%
2025-06-30	5,139,632	5,465,000	94.05%
2025-03-31	5,119,780	5,421,000	94.44%
2024-12-31	5,039,161	5,429,000	92.82%
2024-09-30	4,843,527	5,413,000	89.48%
2024-06-30	4,854,620	5,397,000	89.95%
2024-03-31	4,857,256	5,386,000	90.18%
2023-12-31	4,750,459	5,393,000	88.09%
2023-09-30	4,815,747	5,387,000	89.40%
2023-06-30	4,798,522	5,372,000	89.32%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

MESA LABORATORIES INC /CO/ (MLAB) — SEC Financial Statements & Analysis

MESA LABORATORIES INC /CO/ (MLAB) is a industrial instruments for measurement, display, and control company, incorporated in CO. MESA LABORATORIES INC /CO/ trades on Nasdaq as: MLAB. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), MESA LABORATORIES INC /CO/ reported a 3.04% year-over-year revenue growth, a Gross Profit Margin of 64.21% (TTM), a Debt-to-Equity ratio of 1.22x, a Price-to-Sales (P/S) ratio of 2.26x (TTM), a Price-to-Book (P/B) ratio of 2.98x (TTM), at a market cap of $563.15M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 3.04%
Gross Profit Margin TTM: 64.21%
Debt To Equity: 1.22x
P/S TTM: 2.26x
P/B TTM: 2.98x
Market Cap: $563.15M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is MESA LABORATORIES INC /CO/ in?

MESA LABORATORIES INC /CO/ (MLAB) operates in the Industrial Instruments For Measurement, Display, and Control industry.

What is MLAB's market cap?

MESA LABORATORIES INC /CO/ (MLAB) has a market capitalization of $563.15M as of 2026-06-30.

What is MLAB's P/E ratio?

MESA LABORATORIES INC /CO/ (MLAB)'s trailing twelve month P/E ratio is 117.32x as of 2026-06-30.

What exchange does MLAB trade on?

MESA LABORATORIES INC /CO/ (MLAB) trades on the Nasdaq.

Where is MESA LABORATORIES INC /CO/ incorporated?

MESA LABORATORIES INC /CO/ is incorporated in CO.